The Diabeo Software Enabling Individualized Insulin Dose Adjustments Combined With Telemedicine Support Improves HbA(1c) in Poorly Controlled Type 1 Diabetic Patients: A 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study)

OBJECTIVE: To demonstrate that Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support significantly improves HbA(1c) in poorly controlled type 1 diabetic patients. RESEARCH DESIGN AND METHODS: In a six-month open-label parallel-group, multicenter study, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Charpentier, Guillaume, Benhamou, Pierre-Yves, Dardari, Dured, Clergeot, Annie, Franc, Sylvia, Schaepelynck-Belicar, Pauline, Catargi, Bogdan, Melki, Vincent, Chaillous, Lucy, Farret, Anne, Bosson, Jean-Luc, Penfornis, Alfred
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041176/
https://www.ncbi.nlm.nih.gov/pubmed/21266648
http://dx.doi.org/10.2337/dc10-1259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041176/
https://www.ncbi.nlm.nih.gov/pubmed/21266648
http://dx.doi.org/10.2337/dc10-1259

Ejemplares similares